Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Knockdown of the histone di-methyltransferase G9a in nucleus accumbens shell decreases cocaine self-administration, stress-induced reinstatement, and anxiety.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology | 2019

Comorbid neuropsychiatric disorders such as addiction and anxiety could involve common underlying mechanisms. One potential mechanism involves epigenetic regulation of histone 3 dimethylation at lysine 9 residues (H3K9me2) by the histone dimethyltransferase G9a. Here we provide evidence that local AAV-RNAi-mediated knockdown of G9a expression in nucleus accumbens shell (NAcSh) of male rats reduces both addictive-related and anxiety-related behaviors. Specifically, G9a knockdown reduces sensitivity to low dose cocaine reinforcement when cocaine is freely available (fixed ratio schedule). Similarly, G9a knockdown reduces motivation for cocaine under higher effort demands (progressive ratio schedule). Following several weeks of forced abstinence, G9a knockdown attenuates extinction responding and reinstatement triggered by either cocaine-priming injections or footshock stress. This decrease in addictive behavior is associated with a long-term reduction in anxiety-like behavior as measured by the elevated plus maze (EPM). G9a knockdown also reduces basal anxiety-like behavior in EPM and marble burying tests in drug-naïve rats. These results complement our previous work showing that increased G9a expression in NAcSh enhances addictive-related and anxiety-related behaviors, indicating that G9a bi-directionally controls these responses. These results also suggest that regulation of G9a-influenced gene expression could be a common epigenetic mechanism for co-morbid anxiety and psychostimulant addiction.

Pubmed ID: 30587852 RIS Download

Associated grants

  • Agency: NIDA NIH HHS, United States
    Id: T32 DA007290
  • Agency: NIDA NIH HHS, United States
    Id: R01 DA007359
  • Agency: NIDA NIH HHS, United States
    Id: R37 DA007359
  • Agency: NIDA NIH HHS, United States
    Id: R01 DA014133
  • Agency: NIDA NIH HHS, United States
    Id: R01 DA032708
  • Agency: NIDA NIH HHS, United States
    Id: P01 DA008227
  • Agency: NIMH NIH HHS, United States
    Id: P50 MH096890
  • Agency: NIDA NIH HHS, United States
    Id: R01 DA027664

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Goat Anti-Mouse IgG (H L)-HRP Conjugate (antibody)

RRID:AB_11125547

This unknown targets Goat Mouse IgG (H L)-HRP Conjugate

View all literature mentions

Anti-Beta-Tubulin 3 Antibody (antibody)

RRID:AB_2313564

This polyclonal targets Beta-Tubulin 3

View all literature mentions

Goat Anti-Rabbit IgG (H + L)-HRP Conjugate (antibody)

RRID:AB_11125142

This polyclonal secondary targets IgG (H+L)

View all literature mentions

Histone H3 (di methyl K9) antibody [mAbcam 1220] - ChIP Grade (antibody)

RRID:AB_449854

This monoclonal targets Histone H3 (di methyl K9) antibody [mAbcam 1220] - ChIP Grade

View all literature mentions

KMT1C / G9a antibody - ChIP Grade (antibody)

RRID:AB_731483

This polyclonal targets KMT1C / G9a antibody - ChIP Grade

View all literature mentions